The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
if you are wed to psa using psa volume where you take psa normalized to prostate volume and psa velocity which ezra you would get out of what you propose which is the rate of change of psa over time so psa has a rate of change called psa velocity psa volume become much better indicators of prostate cancer risk than just psa
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.